Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liraglutide in patients with intestinal failure
ChiCTR2000034159Phase 4Recruiting
- Sponsor
- Jinling Hospital
- Start
- Jun 2020
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of liraglutide in intestinal failure (IF) (2 arms), sponsored by Jinling Hospital. Primary endpoints: Nutrition-related indicators, Hepatic and renal function and 1 more. Started Jun 2020; status: recruiting.
02
Drugs
03
Conditions
intestinal failure (IF)
Beyond the preview
Go deeper on ChiCTR2000034159.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000034159.